FFO
BSX icon

Fortitude Family Office’s Boston Scientific BSX Stock Holding History

Fortitude Family Office’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.2K Sell
894
-2,288
-72% -$124K 0.01% 345
2026
Q1 		$200K Sell
3,182
-134
-4% -$10.7K 0.04% 120
2025
Q4 		$316K Sell
3,316
-11
-0.3% -$1.08K 0.07% 116
2025
Q3 		$325K Buy
3,327
+3
+0.1% +$311 0.09% 110
2025
Q2 		$357K Buy
3,324
+2,902
+688% +$294K 0.12% 92
2025
Q1 		$42.6K Sell
422
-59
-12% -$5.94K 0.02% 253
2024
Q4 		$43K Buy
481
+184
+62% +$16.2K 0.02% 283
2024
Q3 		$24.9K Buy
297
+112
+61% +$8.83K 0.01% 374
2024
Q2 		$14.2K Hold
185
– – 0.01% 351
2024
Q1 		$12.7K Hold
185
– – 0.01% 347
2023
Q4 		$10.7K Buy
+185
New +$9.88K 0.01% 392

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Fortitude Family Office's BSX Position: Q2 2026 in Review

Fortitude Family Office reduced its Boston Scientific (BSX) stake by 72% in Q2 2026, selling an estimated $124K and leaving 894 shares worth $38.2K. The position accounts for 0.01% of the portfolio, ranked #345.

Fortitude Family Office first reported a position in BSX in Q4 2023 and has held it in 11 quarters since. The position peaked at $357K in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Fortitude Family Office held 894 shares of Boston Scientific worth $38.2K as of Q2 2026.
  • Fortitude Family Office sold 2,288 Boston Scientific shares in Q2 2026, an estimated $124K.
  • Boston Scientific made up 0.01% of Fortitude Family Office's portfolio in Q2 2026, its #345 holding.
  • Fortitude Family Office first reported a position in Boston Scientific in Q4 2023 and has held it in 11 quarters since.
  • Fortitude Family Office's Boston Scientific position peaked at $357K in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.